Get Your Own businessabc Wiki
Boost credibility, visibility, and discoverability
IGM Biosciences was founded in 2011 in Seattle, WA with a mission to develop novel immunotherapies for the treatment of cancer and autoimmune diseases. The company acquired medicinal chemistry, pharmaceutical, and biopharmaceutical development capabilities in 2013 to build a robust pipeline of innovative therapeutic agents. In 2016, IGM secured a research collaboration with Roche and in 2018 the company commenced its first clinical trial. Today, the company is focused on developing a broad array of next-generation immuno-oncology therapies, while expanding its pipeline of therapeutic modalities.
